相关实验视频

Updated: May 21, 2025

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

基于跨导管动脉化学栓塞的中期和晚期初级肝细胞癌的综合治疗 (评论)

Xing Xu^1,2, Xue Zhang³, Yang Zhao¹

¹Department of Hepatobiliary Surgery, Hebei General Hospital, Shijiazhuang, Hebei 050057, P.R. China.

Oncology letters

|May 19, 2025

概括

肝细胞癌 (HCC) 治疗正在通过透管动脉化学栓塞 (TACE) 组合得到改善. 本综述探讨了基于TACE的多式疗法当前的证据和未来的创新,以改善HCC患者的治疗结果.

科学领域:

肝胆道癌症肝胆道癌症
干预性瘤学干预性瘤学
多种模式的癌症治疗方法

背景情况:

初级肝细胞癌 (HCC) 是一个重要的全球健康问题,死亡率高.
早期疾病检测和晚期手术限制对有效的HCC管理构成了挑战.
过导管动脉化学栓塞 (TACE) 是一个关键的HCC干预,组合策略显示出希望.

研究的目的:

批判性地评估当前的TACE为中心的多式疗法,用于HCC.
探索基于TACE的治疗方法中的新兴创新.
在HCC管理中优化治疗范式和患者预后.

主要方法:

对基于TACE的多式疗法当代临床证据的系统审查.
分析最近的创新和HCC治疗的未来进展.
在TACE中对协同组合策略的评估.

主要成果:

TACE是HCC的关键干预措施,通过组合策略来加强.
目前的证据支持以TACE为中心的多式联运方法.
新兴的创新已经准备好重新定义HCC的治疗边界.

结论:

完善治疗范式需要综合当前的证据,并预测TACE的未来进展.
优化患者预后需要对基于TACE的多式疗法有全面的了解.
该审查对HCC治疗的不断变化的格局进行了批判性评估.

关键词:

肝细胞癌是肝细胞癌.免疫疗法免疫疗法分子向疗法是指分子向疗法.治疗性化学血栓化疗法治疗疗法治疗疗法治疗疗法

更多相关视频

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.